{
    "clinical_study": {
        "@rank": "16614", 
        "acronym": "SIRROUND-LTE", 
        "arm_group": [
            {
                "arm_group_label": "Sirukumab 100 mg", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "Sirukumab 50 mg / placebo", 
                "arm_group_type": "Experimental"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to evaluate the long-term safety and efficacy of CNTO 136\n      (sirukumab) in participants with rheumatoid arthritis (RA) who are unresponsive to treatment\n      with modifying antirheumatic drugs (DMARDs) or anti-TNF alpha agents."
        }, 
        "brief_title": "Long-term Safety and Efficacy of Sirukumab in Participants With RA Completing Studies CNTO136ARA3002 or CNTO136ARA3003", 
        "completion_date": {
            "#text": "November 2019", 
            "@type": "Anticipated"
        }, 
        "condition": "Rheumatoid Arthritis", 
        "condition_browse": {
            "mesh_term": [
                "Arthritis", 
                "Arthritis, Rheumatoid"
            ]
        }, 
        "detailed_description": {
            "textblock": "This is a multicenter, long-term study of sirukumab (CNTO 136) that will be conducted in two\n      groups of participants at the same time (parallel-group study).  The maximum duration of\n      participation in this study is 208 weeks, followed by approximately 16 weeks of safety and\n      efficacy follow-up after the administration of the final study agent injection of sirukumab.\n       Participant safety will be monitored throughout the study."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Completed participation in Studies CNTO136ARA3002 or CNTO136ARA3003\n\n          -  Signed an informed consent form (ICF) indicating that they understand the purpose of\n             and procedures required for the study and are willing to participate in the study\n\n          -  Signed an informed consent form (ICF) for pharmacogenetics research (how a person's\n             genes may affect a drug's effects) in order to participate in the optional\n             pharmacogenetics component of this study. Refusal to give consent for this component\n             does not exclude a participant from participation in this clinical study\n\n        Exclusion Criteria:\n\n          -  Withdraws consent and/or discontinues participation in study CNTO136ARA3002 or\n             CNTO136ARA3003\n\n          -  Is pregnant\n\n          -  Has active diverticulitis\n\n          -  Has any condition that, in the opinion of the investigator, would make participation\n             not be in the best interest (eg, compromise the well-being) of the participant or\n             that could prevent, limit, or confound the protocol-specified assessments"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "2165", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 15, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01856309", 
            "org_study_id": "CR102023", 
            "secondary_id": [
                "CNTO136ARA3004", 
                "2012-001176-10"
            ]
        }, 
        "intervention": [
            {
                "arm_group_label": "Sirukumab 100 mg", 
                "description": "Sirukumab 100 mg subcutaneously (SC) at Weeks 0 (administered as the last dose in CNTO136ARA3002 or CNTO136ARA3003), 2, and every 2 weeks through Week 156 for participants who completed CNTO136ARA3002 and through Week 208 for participants who completed CNTO136ARA3003.", 
                "intervention_name": "Sirukumab 100 mg", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Sirukumab 50 mg / placebo", 
                "description": "Sirukumab 50 mg SC at Weeks 0 (administered as the last dose in CNTO136ARA3002 or CNTO136ARA3003), 4, and every 4 weeks through Week 156 for participants who completed CNTO136ARA3002 and through Week 208 for participants who completed CNTO136ARA3003.", 
                "intervention_name": "Sirukumab 50 mg", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Sirukumab 50 mg / placebo", 
                "description": "Between sirukumab 50 mg injections, placebo SC injections will be administered at Weeks 2, 6, and every 4 weeks until the study becomes open-label, and placebo injections are discontinued.", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Rheumatoid Arthritis", 
            "Sirukumab", 
            "CNTO 136", 
            "CNTO136ARA3002", 
            "SIRROUND-D", 
            "CNTO136ARA3003", 
            "SIRROUND-T", 
            "SIRROUND-LTE"
        ], 
        "lastchanged_date": "April 22, 2014", 
        "link": {
            "description": "To learn how to participate in this trial please click here.", 
            "url": "http://pam.sylogent.com/cr/CR102023"
        }, 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Phoenix", 
                        "country": "United States", 
                        "state": "Arizona"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cerritos", 
                        "country": "United States", 
                        "state": "California"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Huntington Beach", 
                        "country": "United States", 
                        "state": "California"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lakewood", 
                        "country": "United States", 
                        "state": "California"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Victorville", 
                        "country": "United States", 
                        "state": "California"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Whittier", 
                        "country": "United States", 
                        "state": "California"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Aventura", 
                        "country": "United States", 
                        "state": "Florida"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Debary", 
                        "country": "United States", 
                        "state": "Florida"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Palm Harbor", 
                        "country": "United States", 
                        "state": "Florida"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Plantation", 
                        "country": "United States", 
                        "state": "Florida"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Zephyrhills", 
                        "country": "United States", 
                        "state": "Florida"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cedar Rapids", 
                        "country": "United States", 
                        "state": "Iowa"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Springfield", 
                        "country": "United States", 
                        "state": "Missouri"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Omaha", 
                        "country": "United States", 
                        "state": "Nebraska"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Freehold", 
                        "country": "United States", 
                        "state": "New Jersey"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Albuquerque", 
                        "country": "United States", 
                        "state": "New Mexico"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Dayton", 
                        "country": "United States", 
                        "state": "Ohio"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Edmond", 
                        "country": "United States", 
                        "state": "Oklahoma"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tulsa", 
                        "country": "United States", 
                        "state": "Oklahoma"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lubbock", 
                        "country": "United States", 
                        "state": "Texas"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Mesquite", 
                        "country": "United States", 
                        "state": "Texas"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Beckley", 
                        "country": "United States", 
                        "state": "West Virginia"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Quilmes", 
                        "country": "Argentina"
                    }
                }, 
                "status": "Withdrawn"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Ixelles", 
                        "country": "Belgium"
                    }
                }, 
                "status": "Withdrawn"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Winnipeg", 
                        "country": "Canada", 
                        "state": "Manitoba"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Berlin", 
                        "country": "Germany"
                    }
                }, 
                "status": "Withdrawn"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Dresden", 
                        "country": "Germany"
                    }
                }, 
                "status": "Withdrawn"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Schwerin", 
                        "country": "Germany"
                    }
                }, 
                "status": "Withdrawn"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Zerbst", 
                        "country": "Germany"
                    }
                }, 
                "status": "Withdrawn"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kagoshima", 
                        "country": "Japan"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kato", 
                        "country": "Japan"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kumamoto", 
                        "country": "Japan"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nagasaki", 
                        "country": "Japan"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nagoya", 
                        "country": "Japan"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sapporo", 
                        "country": "Japan"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Shimotsuke", 
                        "country": "Japan"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Shinjuku-Ku", 
                        "country": "Japan"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sumida-Ku", 
                        "country": "Japan"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Takaoka,Toyama", 
                        "country": "Japan"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Takasaki", 
                        "country": "Japan"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Ureshino", 
                        "country": "Japan"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Daegu", 
                        "country": "Korea, Republic of"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Incheon", 
                        "country": "Korea, Republic of"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kaunas", 
                        "country": "Lithuania"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Guadalajara, Jalisco", 
                        "country": "Mexico"
                    }
                }, 
                "status": "Withdrawn"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Barnaul", 
                        "country": "Russian Federation"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Moscow", 
                        "country": "Russian Federation"
                    }
                }, 
                "status": "Withdrawn"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Coru\u00f1a", 
                        "country": "Spain"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Madrid", 
                        "country": "Spain"
                    }
                }, 
                "status": "Withdrawn"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Santiago De Compostela", 
                        "country": "Spain"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Changhua", 
                        "country": "Taiwan"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kaohsiung", 
                        "country": "Taiwan"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Taichung", 
                        "country": "Taiwan"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Taichung City", 
                        "country": "Taiwan"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Taipei", 
                        "country": "Taiwan"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Ternopil", 
                        "country": "Ukraine"
                    }
                }, 
                "status": "Withdrawn"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Dorset", 
                        "country": "United Kingdom"
                    }
                }, 
                "status": "Withdrawn"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Essex", 
                        "country": "United Kingdom"
                    }
                }, 
                "status": "Withdrawn"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Liverpool", 
                        "country": "United Kingdom"
                    }
                }, 
                "status": "Withdrawn"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Manchester", 
                        "country": "United Kingdom"
                    }
                }, 
                "status": "Withdrawn"
            }
        ], 
        "location_countries": {
            "country": [
                "United States", 
                "Argentina", 
                "Belgium", 
                "Canada", 
                "Germany", 
                "Japan", 
                "Korea, Republic of", 
                "Lithuania", 
                "Mexico", 
                "Russian Federation", 
                "Spain", 
                "Taiwan", 
                "Ukraine", 
                "United Kingdom"
            ]
        }, 
        "number_of_arms": "2", 
        "official_title": "A Multicenter, Parallel-group Study of Long-term Safety and Efficacy of CNTO 136 (Sirukumab) for Rheumatoid Arthritis in Subjects Completing Treatment in Studies CNTO136ARA3002 (SIRROUND-D) and CNTO136ARA3003 (SIRROUND-T)", 
        "overall_contact": {
            "email": "JNJ.CT@sylogent.com", 
            "last_name": "Use link at the bottom of the page to see if you qualify for an enrolling site (see list). If you still have questions:"
        }, 
        "overall_official": {
            "affiliation": "Janssen Research & Development, LLC", 
            "last_name": "Janssen Research & Development, LLC Clinical Trial", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "November 2019", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "measure": "The number of participants with cardiovascular serious adverse events (SAEs)", 
                "safety_issue": "No", 
                "time_frame": "Up to 224 weeks"
            }, 
            {
                "measure": "The number of participants with malignancies", 
                "safety_issue": "No", 
                "time_frame": "Up to 224 weeks"
            }, 
            {
                "measure": "The number of participants with serious infections", 
                "safety_issue": "No", 
                "time_frame": "Up to 224 weeks"
            }, 
            {
                "measure": "The number of participants with gastrointestinal perforations", 
                "safety_issue": "No", 
                "time_frame": "Up to 224 weeks"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01856309"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Observations of laboratory parameters of interest (neutrophils, platelets, hepatobiliary parameters, and lipid parameters)", 
                "safety_issue": "No", 
                "time_frame": "Up to 224 weeks"
            }, 
            {
                "measure": "Summary of toxicity grading", 
                "safety_issue": "No", 
                "time_frame": "Up to 224 weeks"
            }, 
            {
                "description": "American College of Rheumatology (ACR) 20 response is a >=20% improvement in rheumatoid arthritis (RA) symptoms.", 
                "measure": "Proportion of participants who achieve ACR 20 response", 
                "safety_issue": "No", 
                "time_frame": "Up to 208 weeks"
            }, 
            {
                "description": "ACR 50 response is a >=50% improvement in RA symptoms.", 
                "measure": "Proportion of participants who achieve ACR 50 response", 
                "safety_issue": "No", 
                "time_frame": "Up to 208 weeks"
            }, 
            {
                "description": "ACR 70 response is a >=70% improvement in RA symptoms.", 
                "measure": "Proportion of participants who achieve ACR 70 response", 
                "safety_issue": "No", 
                "time_frame": "Up to 208 weeks"
            }, 
            {
                "description": "DAS28 (using CRP [C-reactive protein]) response is improvement from baseline, with >1.2 indicating a good or moderate response and <=0.6 indicating no response.", 
                "measure": "Proportion of participants with DAS28 (CRP) response", 
                "safety_issue": "No", 
                "time_frame": "Up to 208 weeks"
            }, 
            {
                "description": "DAS28 (using CRP [C-reactive protein]) remission is defined as a value of <2.6 on the Disease Activity Index, a measure of tender and swollen joints and the patient's assessment of disease activity.", 
                "measure": "Proportion of participants with DAS28 (CRP) remission", 
                "safety_issue": "No", 
                "time_frame": "Up to 208 weeks"
            }, 
            {
                "description": "DAS28 (using CRP [C-reactive protein]) is a measure of tender and swollen joints and the patient's assessment of disease activity.", 
                "measure": "Change from baseline in DAS28 (CRP)", 
                "safety_issue": "No", 
                "time_frame": "Up to 208 weeks"
            }, 
            {
                "description": "The Simplified Disease Activity Index (SDAI)-based ACR/EULAR (European League Against Rheumatism) remission is defined as a SDAI value of <=3.3 at a visit.", 
                "measure": "Proportion of participants with SDAI-based ACR/EULAR remission", 
                "safety_issue": "No", 
                "time_frame": "Up to 208 weeks"
            }, 
            {
                "description": "Boolean-based ACR/EULAR remission is achieved if all of the following 4 criteria at that visit are met: tender joint count (68 joints) <=1; swollen joint count (66 joints) <= 1; CRP <=1 mg/dL; and Patient's Global Assessment of Disease Activity on VAS <=1 on a 0 to 10 scale.", 
                "measure": "Proportion of participants with Boolean-based ACR/EULAR remission", 
                "safety_issue": "No", 
                "time_frame": "Up to 208 weeks"
            }, 
            {
                "description": "The Simplified Disease Activity Index (SDAI) score is a derived score combining tender joints (28 joints), swollen joints (28 joints), Patient's Global Assessment of Disease Activity, Physician's Global Assessments of Disease Activity, and CRP.", 
                "measure": "Change from baseline in SDAI", 
                "safety_issue": "No", 
                "time_frame": "Up to 208 weeks"
            }, 
            {
                "description": "Clinical Disease Activity Index (CDAI) score is a derived score combining tender joints (28 joints), swollen joints (28 joints), Patient's Global Assessment of Disease Activity, and Physician's Global Assessments of Disease Activity.", 
                "measure": "Change from baseline in CDAI", 
                "safety_issue": "No", 
                "time_frame": "Up to 208 weeks"
            }, 
            {
                "description": "The Health Assessment Questionnaire-Disability Index (HAQ-DI) assesses the degree of difficulty a person has in accomplishing tasks in 8 functional areas, each scored from 0 (no difficulty) to 3 (inability to perform a task).", 
                "measure": "Change from baseline in HAQ-DI", 
                "safety_issue": "No", 
                "time_frame": "Up to 208 weeks"
            }, 
            {
                "description": "The Health Assessment Questionnaire-Disability Index (HAQ-DI) assesses the degree of difficulty a person has in accomplishing tasks in 8 functional areas, each scored from 0 (no difficulty) to 3 (inability to perform a task).", 
                "measure": "Proportion of HAQ-DI responders (ie, those who have a change from baseline of > 0.22 in HAQ-DI score)", 
                "safety_issue": "No", 
                "time_frame": "Up to 208 weeks"
            }, 
            {
                "description": "The Physical Component Score is a summary score with higher scores indicating better health.", 
                "measure": "Change from baseline in Physical Component Score (PCS)", 
                "safety_issue": "No", 
                "time_frame": "Up to 208 weeks"
            }, 
            {
                "description": "The Mental Component Score is a summary score with higher scores indicating better health.", 
                "measure": "Change from baseline in Mental Component Score (MCS)", 
                "safety_issue": "No", 
                "time_frame": "Up to 208 weeks"
            }, 
            {
                "description": "The SF-36 is a medical outcome study health measure and consists of 8 multi-item scales that are scored from 0 to 100, with higher scores indicating better health.", 
                "measure": "Change from baseline in domain scores of 36-item short form health survey (SF-36)", 
                "safety_issue": "No", 
                "time_frame": "Up to 208 weeks"
            }
        ], 
        "source": "Janssen Research & Development, LLC", 
        "sponsors": {
            "collaborator": {
                "agency": "GlaxoSmithKline", 
                "agency_class": "Industry"
            }, 
            "lead_sponsor": {
                "agency": "Janssen Research & Development, LLC", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "August 2013", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}